Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.

Lopez CK, Noguera E, Stavropoulou V, Robert E, Aid Z, Ballerini P, Bilhou-Nabera C, Lapillonne H, Boudia F, Thirant C, Fagnan A, Arcangeli ML, Kinston SJ, Diop M, Job B, Lecluse Y, Brunet E, Babin L, Villeval JL, Delabesse E, Peters AHFM, Vainchenker W, Gaudry M, Masetti R, Locatelli F, Malinge S, Nerlov C, Droin N, Lobry C, Godin I, Bernard OA, Göttgens B, Petit A, Pflumio F, Schwaller J, Mercher T.

Cancer Discov. 2019 Dec;9(12):1736-1753. doi: 10.1158/2159-8290.CD-18-1463. Epub 2019 Oct 29.

PMID:
31662298
2.

Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH).

Lobry C, Bains A, Zamechek LB, Ibrahim S, Aifantis I, Araten DJ.

Exp Hematol Oncol. 2019 Aug 21;8:17. doi: 10.1186/s40164-019-0142-0. eCollection 2019.

3.

Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.

Bencheikh L, Diop MK, Rivière J, Imanci A, Pierron G, Souquere S, Naimo A, Morabito M, Dussiot M, De Leeuw F, Lobry C, Solary E, Droin N.

Nat Commun. 2019 Apr 26;10(1):1935. doi: 10.1038/s41467-019-09970-9.

4.

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F.

Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5.

PMID:
29403038
5.

Asymmetric dispersal in the multi-patch logistic equation.

Arditi R, Lobry C, Sari T.

Theor Popul Biol. 2018 Mar;120:11-15. doi: 10.1016/j.tpb.2017.12.006. Epub 2017 Dec 24.

PMID:
29278681
6.

ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.

Thirant C, Ignacimouttou C, Lopez CK, Diop M, Le Mouël L, Thiollier C, Siret A, Dessen P, Aid Z, Rivière J, Rameau P, Lefebvre C, Khaled M, Leverger G, Ballerini P, Petit A, Raslova H, Carmichael CL, Kile BT, Soler E, Crispino JD, Wichmann C, Pflumio F, Schwaller J, Vainchenker W, Lobry C, Droin N, Bernard OA, Malinge S, Mercher T.

Cancer Cell. 2017 Mar 13;31(3):452-465. doi: 10.1016/j.ccell.2017.02.006.

7.

BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.

Valls E, Lobry C, Geng H, Wang L, Cardenas M, Rivas M, Cerchietti L, Oh P, Yang SN, Oswald E, Graham CW, Jiang Y, Hatzi K, Agirre X, Perkey E, Li Z, Tam W, Bhatt K, Leonard JP, Zweidler-McKay PA, Maillard I, Elemento O, Ci W, Aifantis I, Melnick A.

Cancer Discov. 2017 May;7(5):506-521. doi: 10.1158/2159-8290.CD-16-1189. Epub 2017 Feb 23.

8.

A density-dependent model of competition for one resource in the chemostat.

Fekih-Salem R, Lobry C, Sari T.

Math Biosci. 2017 Apr;286:104-122. doi: 10.1016/j.mbs.2017.02.007. Epub 2017 Feb 14.

PMID:
28212840
9.

Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.

Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O.

Nat Med. 2016 Jun 7;22(6):692. doi: 10.1038/nm0616-692d. No abstract available.

10.

Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation.

Proudhon C, Snetkova V, Raviram R, Lobry C, Badri S, Jiang T, Hao B, Trimarchi T, Kluger Y, Aifantis I, Bonneau R, Skok JA.

Cell Rep. 2016 Jun 7;15(10):2159-2169. doi: 10.1016/j.celrep.2016.04.087. Epub 2016 May 26.

11.

Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.

Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O.

Nat Med. 2016 Jun;22(6):672-8. doi: 10.1038/nm.4097. Epub 2016 May 2. Erratum in: Nat Med. 2016 Jun 7;22(6):692.

12.

Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.

Diouf M, Filleron T, Pointet AL, Dupont-Gossard AC, Malka D, Artru P, Gauthier M, Lecomte T, Aparicio T, Thirot-Bidault A, Lobry C, Fein F, Dubreuil O, Landi B, Zaanan A, Taieb J, Bonnetain F.

Qual Life Res. 2016 Jul;25(7):1713-23. doi: 10.1007/s11136-015-1198-x. Epub 2015 Nov 28.

PMID:
26615615
13.

Is dispersal always beneficial to carrying capacity? New insights from the multi-patch logistic equation.

Arditi R, Lobry C, Sari T.

Theor Popul Biol. 2015 Dec;106:45-59. doi: 10.1016/j.tpb.2015.10.001. Epub 2015 Oct 16.

PMID:
26472064
14.

Restoring Ikaros's wings to solve a leukemia maze.

Lobry C.

Blood. 2015 Oct 8;126(15):1735-6. doi: 10.1182/blood-2015-08-662544.

PMID:
26450952
15.

Erratum: TET1 is a tumor suppressor of hematopoietic malignancy.

Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, Shen S, Verma AK, Jaenisch R, Aifantis I.

Nat Immunol. 2015 Aug;16(8):889. doi: 10.1038/ni0815-889a. No abstract available.

PMID:
26194287
16.

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.

Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, Cho H, Kim MK, Zebari AS, Aumann S, Park CY, Buonamici S, Smith PG, Deeg HJ, Lobry C, Aifantis I, Modis Y, Allain FH, Halene S, Bradley RK, Abdel-Wahab O.

Cancer Cell. 2015 May 11;27(5):617-30. doi: 10.1016/j.ccell.2015.04.006.

17.

TET1 is a tumor suppressor of hematopoietic malignancy.

Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, Shen S, Verma AK, Jaenisch R, Aifantis I.

Nat Immunol. 2015 Jun;16(6):653-62. doi: 10.1038/ni.3148. Epub 2015 Apr 13. Erratum in: Nat Immunol. 2015 Aug;16(8):889.

18.

Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).

Trouilloud I, Dupont-Gossard AC, Malka D, Artru P, Gauthier M, Lecomte T, Aparicio T, Thirot-Bidault A, Lobry C, Asnacios A, Manet-Lacombe S, Fein F, Dubreuil O, Landi B, Zaanan A, Bonnetain F, Taïeb J.

Eur J Cancer. 2014 Dec;50(18):3116-24. doi: 10.1016/j.ejca.2014.09.015. Epub 2014 Oct 17.

PMID:
25454414
19.

STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.

Gough DJ, Marié IJ, Lobry C, Aifantis I, Levy DE.

Blood. 2014 Oct 2;124(14):2252-61. doi: 10.1182/blood-2013-02-484196. Epub 2014 Aug 22.

20.

Notch signaling: switching an oncogene to a tumor suppressor.

Lobry C, Oh P, Mansour MR, Look AT, Aifantis I.

Blood. 2014 Apr 17;123(16):2451-9. doi: 10.1182/blood-2013-08-355818. Epub 2014 Mar 7. Review.

21.

In vivo mapping of notch pathway activity in normal and stress hematopoiesis.

Oh P, Lobry C, Gao J, Tikhonova A, Loizou E, Manet J, van Handel B, Ibrahim S, Greve J, Mikkola H, Artavanis-Tsakonas S, Aifantis I.

Cell Stem Cell. 2013 Aug 1;13(2):190-204. doi: 10.1016/j.stem.2013.05.015. Epub 2013 Jun 20. Erratum in: Cell Stem Cell. 2013 Aug 1;13(2):256. Manet, Jan [corrected to Manent, Jan].

22.

A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics.

Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM.

Int J Hepatol. 2013;2013:314868. doi: 10.1155/2013/314868. Epub 2013 Mar 7.

23.

Distinct TCR signaling pathways drive proliferation and cytokine production in T cells.

Guy CS, Vignali KM, Temirov J, Bettini ML, Overacre AE, Smeltzer M, Zhang H, Huppa JB, Tsai YH, Lobry C, Xie J, Dempsey PJ, Crawford HC, Aifantis I, Davis MM, Vignali DA.

Nat Immunol. 2013 Mar;14(3):262-70. doi: 10.1038/ni.2538. Epub 2013 Feb 3.

24.

Notch pathway activation targets AML-initiating cell homeostasis and differentiation.

Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, Ibrahim S, Skokos D, Armstrong SA, Levine RL, Park CY, Aifantis I.

J Exp Med. 2013 Feb 11;210(2):301-19. doi: 10.1084/jem.20121484. Epub 2013 Jan 28.

25.

Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.

Billiard F, Lobry C, Darrasse-Jèze G, Waite J, Liu X, Mouquet H, DaNave A, Tait M, Idoyaga J, Leboeuf M, Kyratsous CA, Burton J, Kalter J, Klinakis A, Zhang W, Thurston G, Merad M, Steinman RM, Murphy AJ, Yancopoulos GD, Aifantis I, Skokos D.

J Exp Med. 2012 May 7;209(5):1011-28. doi: 10.1084/jem.20111615. Epub 2012 Apr 30.

26.

T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.

Germar K, Dose M, Konstantinou T, Zhang J, Wang H, Lobry C, Arnett KL, Blacklow SC, Aifantis I, Aster JC, Gounari F.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20060-5. doi: 10.1073/pnas.1110230108. Epub 2011 Nov 22.

27.

Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.

Lobry C, Oh P, Aifantis I.

J Exp Med. 2011 Sep 26;208(10):1931-5. doi: 10.1084/jem.20111855. Review.

28.

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, Perna F, Pandey S, Madzo J, Song C, Dai Q, He C, Ibrahim S, Beran M, Zavadil J, Nimer SD, Melnick A, Godley LA, Aifantis I, Levine RL.

Cancer Cell. 2011 Jul 12;20(1):11-24. doi: 10.1016/j.ccr.2011.06.001. Epub 2011 Jun 30.

29.

A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.

Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E, Liu C, Ibrahim S, Beran M, Zavadil J, Efstratiadis A, Taghon T, Michor F, Levine RL, Aifantis I.

Nature. 2011 May 12;473(7346):230-3. doi: 10.1038/nature09999.

30.

PHF6 mutations in adult acute myeloid leukemia.

Van Vlierberghe P, Patel J, Abdel-Wahab O, Lobry C, Hedvat CV, Balbin M, Nicolas C, Payer AR, Fernandez HF, Tallman MS, Paietta E, Melnick A, Vandenberghe P, Speleman F, Aifantis I, Cools J, Levine R, Ferrando A.

Leukemia. 2011 Jan;25(1):130-4. doi: 10.1038/leu.2010.247. Epub 2010 Oct 29.

31.

Bacteria can form interconnected microcolonies when a self-excreted product reduces their surface motility: evidence from individual-based model simulations.

Mabrouk N, Deffuant G, Tolker-Nielsen T, Lobry C.

Theory Biosci. 2010 Jun;129(1):1-13. doi: 10.1007/s12064-009-0078-8. Epub 2009 Nov 28.

PMID:
19946800
32.

Association between competition and obligate mutualism in a chemostat.

El Hajji M, Harmand J, Chaker H, Lobry C.

J Biol Dyn. 2009 Nov;3(6):635-47. doi: 10.1080/17513750902915978.

PMID:
22880965
33.

Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.

Nguyen-Khac E, Ollivier I, Aparicio T, Moullart V, Hugentobler A, Lebtahi R, Lobry C, Susini C, Duhamel C, Hommel S, Cadranel JF, Joly JP, Barbare JC, Tramier B, Dupas JL.

Cancer Biol Ther. 2009 Nov;8(21):2033-9. Epub 2009 Nov 5.

PMID:
19738430
34.

[Premalignant gastric lesions (except lymphomas)].

Lobry C, Aparicio T, Vallot T.

Rev Prat. 2008 Sep 15;58(13):1445-9. French.

PMID:
18924329
35.

[Regulation of NF-kappaB pathway in T lymphocytes].

Lobry C, Weil R.

Med Sci (Paris). 2007 Oct;23(10):857-61. Review. French.

36.

[New Bcl10 regulation mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?].

Lobry C, Weil R.

Med Sci (Paris). 2007 Apr;23(4):353-5. French. No abstract available.

37.

Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.

Lobry C, Lopez T, Israël A, Weil R.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):908-13. Epub 2007 Jan 9.

38.
39.

[Role of peritoneal scintigraphy for the diagnosis of hepatic hydrothorax].

Lobry C, Jouannaud V, Zaneski B, Faroui NE, Wioland M, Khamassi A, Le Lann P, Cadranel JF.

Gastroenterol Clin Biol. 2005 Dec;29(12):1301-2. French. No abstract available.

40.

[On a density-dependent model of competition for one resource].

Lobry C, Rapaport A, Mazenc F.

C R Biol. 2006 Feb;329(2):63-70. Epub 2005 Dec 20. French.

PMID:
16439334
41.

A new hypothesis to explain the coexistence of n species in the presence of a single resource.

Lobry C, Harmand J.

C R Biol. 2006 Jan;329(1):40-6. Epub 2005 Dec 2.

PMID:
16399642
42.

Combinatorial properties of some cellular automata related to the mosaic cycle concept.

Lobry C, Elmoznino H.

Acta Biotheor. 2000 Dec;48(3-4):219-42.

PMID:
11291942
43.
44.

[Australia antigen. Clinical study of detection methods. Effects on the physio-pathological interpretation of viral hepatitis].

Delmas-Marsalet Y, Paris JC, Lobry C, Filoche B, Bleuet M, Hazard C.

Lille Med. 1972 Aug-Sep;17(7):960-3. French. No abstract available.

PMID:
4629269
45.

[Study of a family with hereditary angioneurotic edema (HAE)].

Delmas-Marsalet Y, Hennache G, Lobry C, Boudringhin M, Lefebvre J.

Nouv Rev Fr Hematol. 1972 Jul-Aug;12(4):549-55. French. No abstract available.

PMID:
4404673

Supplemental Content

Support Center